Clinical trial
A Randomized, Parallel, Double-dummy, Multi-center Phase III Study for Evaluation of Efficacy and Safety of Nasotestt Compared to Androgel Treating Hypogonadism in Male Research Participants.
NCT03281187 is registered in ClinicalTrials.gov with FBM Industria Brasileira Ltda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Parallel, Double-dummy, Multi-center Phase III Study for Evaluation of Efficacy and Safety of Nasotestt Compared to Androgel Treating Hypogonadism in Male Research Participants.
- Lead sponsor
- FBM Industria Brasileira Ltda
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 16, 2018
- Completion date
- January 13, 2020
- Enrollment
- 228 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.